Skip To Main Content
Sachin Vishwakarma on Muck Rack

Sachin Vishwakarma

As seen in: BioRxiv, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sachin

Contact Sachin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Graph neural networks best guide phenotypic virtual screening on cancer cell lines

|
By Sachin Vishwakarma, Saiveth Hernández-Hernández, Pedro J. Ballester, Evotec SAS
| BioRxiv
Abstract Artificial intelligence is increasingly driving early drug design, offering novel approaches to virtual screening. Phenotypic virtual screening (PVS) aims to predict how cancer cell lines respond to different compounds by focusing on observable characteristics rather than specific molecular targets. Some studies have suggested that deep learning may not be the best approach for PVS.
Open in Who Shared Issue with article?

Enhanced oral bioavailability of levormeloxifene and raloxifene by nanoemulsion: simultaneous bioanalysis using liquid chromatography-tandem mass spectrometry | Nanomedicine

|
By Divya Chauhan, Pavan Yadav, Debalina Maity, Sachin Vishwakarma
| Future Medicine Verified
Supplemental Materials MetricsHistory Received 27 January 2024 Accepted 5 March 2024 Published online 19 April 2024 Information © 2024 Expert Publishing Medicine Ltd trading as Taylor & Francis KeywordsSupplementary data To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/nnm-2024-0023 Author contributions D Chauhan: writing – original draft, methodology, investigation, formal analysis, data curation.
Open in Who Shared View Duplicates (4) Issue with article?
See all 2 articles